4.6 Article

A novel GATA5 loss-of-function mutation underlies lone atrial fibrillation

Journal

INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE
Volume 31, Issue 1, Pages 43-50

Publisher

SPANDIDOS PUBL LTD
DOI: 10.3892/ijmm.2012.1189

Keywords

atrial fibrillation; genetics; transcription factor; GATA5

Funding

  1. National Natural Science Fund of China [81000082, 81070153, 30570768]
  2. National Basic Research Program of China [2010CB912604]
  3. Personnel Development Foundation of Shanghai, China [2010019]
  4. Key Program of Basic Research of Shanghai, China [10JC1414000, 10JC1414001, 10JC1414002]

Ask authors/readers for more resources

Atrial fibrillation (AF), the most common sustained cardiac arrhythmia, is associated with significantly increased morbidity and mortality. Cumulative evidence highlights the importance of genetic defects in the pathogenesis of AF. However, AF is of remarkable heterogeneity and the genetic determinants of AF in a vast majority of patients remain illusive. In this study, the coding exons and splice junctions of the GATA5 gene, which encodes a zinc-finger transcription factor essential for normal cardiogenesis, were sequenced in 118 unrelated patients with lone AF. The available relatives of the index patient carrying an identified mutation and 200 unrelated ethnically-matched healthy individuals used as controls were genotyped. The functional effect of the mutant GATA5 was characterized in contrast to its wild-type counterpart using a luciferase reporter assay system. As a result, a novel heterozygous GATA5 mutation, p.W200G, was identified in a family with AF inherited as an autosomal dominant trait. The mutation was absent in 200 control individuals and the altered amino acid was completely conserved evolutionarily across species. Functional analysis showed that the mutation of GATA5 was associated with a significantly decreased transcriptional activity. These findings provide novel insight into the molecular mechanism involved in AF, suggesting potential implications for the early prophylaxis and gene-specific therapy of AF.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available